Moreover, those results demonstrated that hepatic expression of CD14 (mCD14) may be an important factor in NASH development because it enhances the hepatic inflammatory response against LPS derived from gut bacteria. The gene discussed is CD14; the disease is metabolic dysfunction-associated steatohepatitis.